Banophen Oral Solution recalled over manufacturing violations
- Recall date
- May 21, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Torrent Pharma Inc recalls Banophen Oral Solution, Sugar Free, Alcohol Free, Cherry Flavor, (Diphenhydramine HCl, USP) Each teaspoonful contains d…
- Recall number
- D-1352-2019
- FDA classification
- Class II
- Brand / firm
- Torrent Pharma Inc
- Sold / distributed
- Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.
Why it was recalled
cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Banophen Oral Solution, Sugar Free, Alcohol Free, Cherry Flavor, (Diphenhydramine HCl, USP) Each teaspoonful contains diphenhydramine hydrochloride, USP 12.5 mg, a) 4 Fl. oz. (118 mL) bottle, NDC: 0904-1228-00, b) One Pint (473 mL) bottle, NDC: 0904-5174-16, Distributed by Major Pharmaceuticals, Livonia MI 48152.
Get recall alerts
Free email alert whenever Torrent Pharma Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Torrent Pharma Inc